Interstitial Lung Disease News

In patients with fibrotic interstitial lung disease, exposure to small particulate matter was linked to increased mortality, poor lung function and faster disease progression, according to a study in JAMA Internal Medicine.

NASHVILLE, Tenn. — Patients who received immune checkpoint inhibitor therapy may have a greater risk for sarcoidosis, according to study results presented at CHEST Annual Meeting.

Although rare organ involvement with sarcoidosis may be indicative of more severe disease, it often does not require treatment, according to data published in Respiratory Medicine.

Variations in chronic respiratory disease mortality appeared to be associated with U.S. county-level sociodemographic vulnerabilities, researchers reported in Annals of the American Thoracic Society.

Sept. 14 marks the second annual ILD Day, which aims to increase awareness of interstitial lung diseases.

The Healio Editors compiled the most-read news in pulmonology posted in April.

A new review published in JAMA highlights the current diagnosis and treatment of pulmonary sarcoidosis.

Electronic nose technology accurately distinguished patients with sarcoidosis from those with interstitial lung disease and healthy controls, researchers reported in Chest.

Riociguat treatment significantly improved exercise capacity and prevented clinical worsening in patients with sarcoidosis-associated pulmonary hypertension, according to study results published in Chest.

Kristin B. Highland, MD, does it all and makes it look easy. In this episode, we discuss how to follow your dreams, balance your life and define success on your own terms.